Trials / Conditions / Advanced Dedifferentiated Liposarcoma
Advanced Dedifferentiated Liposarcoma
3 registered clinical trials studyying Advanced Dedifferentiated Liposarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) fo NCT06498648 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Active Not Recruiting | Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma NCT05694871 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Active Not Recruiting | SARC041: Study of Abemaciclib Versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma NCT04967521 | Sarcoma Alliance for Research through Collaboration | Phase 3 |